ReviewToxins2021
Lantox-The Chinese Botulinum Toxin Drug-Complete English Bibliography and Comprehensive Formalised Literature Review.
Review in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 19 citations in OpenAlex.
- Therapeutic botulinum toxin preparations: an update.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Korean botulinum toxins.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Effective Botulinum Toxin Treatment in Patients With Different Patterns of Cervical Dystonia: A Retrospective SPECT and EMG Study.Journal of movement disorders · 2026Article
- Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis.Journal of cosmetic dermatology · 2026Article
- [Botulinum toxin preparations in dermatology : Characterization, comparison, and treatment options].Dermatologie (Heidelberg, Germany) · 2026Review
- Research progress in the use of botulinum toxin type a for post-stroke spasticity rehabilitation: a narrative review.Annals of medicine · 2025Review
- A Rare Case of Delayed-Onset Hypersensitivity Reaction and Complete Secondary Treatment Failure Following Repeated Cosmetic Botulinum Toxin Type A Injections.Journal of cosmetic dermatology · 2025Article
- Round-Sharp Needle for Limb Spasms After a Stroke: Study Protocol for a Randomized Controlled Trial.Journal of multidisciplinary healthcare · 2025Article
- Review
- Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity.Toxins · 2024Review
- Industrial Production and Therapeutic Application of Botulinum Neurotoxin: The Role ofPharmaceutical nanotechnology · 2024Review
- Botulinum toxin therapy: past, present and future developments.Journal of neural transmission (Vienna, Austria : 1996) · 2022Review
- Pivotal role of obliquus capitis inferior in torticaput revealed by single-photon emission computed tomography.Journal of neural transmission (Vienna, Austria : 1996) · 2022Article
- Retroform Cervical Dystonia: Target Muscle Selection and Efficacy of Botulinum Toxin Injection.Frontiers in neurology · 2022Article
- Comparing lanbotulinumtoxinA (HengliJournal of neural transmission (Vienna, Austria : 1996) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
Abstract
In 1997, lanbotulinumtoxinA (LAN) was introduced in China. It is now available in Asia, Latin America and Eastern Europe under various brand names including Hengli
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.